UICC Asia BG Lab Period SPCC

Exploring the Pathological and Molecular Perspectives of HER2-positive Breast Cancer – SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:

“HER2-positive breast cancer remains one of the most studied yet complex challenges in oncology.

Join us for a live webinar that will bring together leading experts to explore the pathological and molecular perspectives shaping the future of personalised treatment strategies.

28 October 2025 | 18:00 CET

Discussant: Aleksandra Filipovic MD Ph.D. (UK)
Experts: Mattia Rediti (IT), Esther Sanfeliu (ES)

Register now.

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.

This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

Part of the Definitive Trial.”

Exploring the Pathological and Molecular Perspectives of HER2-positive Breast Cancer - SPCC

More Posts Featuring SPCC.